cdc vaccine - Search News

Order byBest matchMost fresh

RFK Jr. fires ‘Washingtonian of year’ from CDC vaccine panel

Digest more

Top News

Overview

Reactions and opinions

· 6h · on MSN

CDC vaccine advisers who were removed from committee by RFK Jr. speak out

The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened."

· 5h · on MSN

Former CDC advisers say they are ‘deeply concerned’ RFK Jr.’s actions will critically weaken US vaccine program

· 6h · on MSN

Dismissed members of CDC vaccine committee call Kennedy’s actions ‘destabilizing’

· 1d

How one meeting in 2020 and a GOP senator helped create RFK Jr.’s vaccine wreck

Liberal ideology and Republican politics laid groundwork for Kennedy’s remaking of the CDC’s vaccine panel.

· 13h

Who Is on RFK, Jr.’s New Vaccine Panel—And What Will They Do?

· 1d

RFK Jr.’s mass firing of vaccine advisory panel misses the mark

· 12h

Bill Cassidy Blew It

Cassidy has continued to give Kennedy the benefit of the doubt.

· 7h

RFK Jr. and MAHA agenda divide country but vaccines have widespread support: Poll

WNCT · 16h

RFK Jr.’s vaccine moves raise fears ahead of next school year

3don MSN

Kennedy's new CDC panel includes members who have criticized vaccines, spread misinformation

Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. They include a scientist who researched mRNA vaccine technology and became a conservative darling for his criticisms of COVID-19 vaccines,

5don MSN

CDC purges career officials from oversight of vaccine committee

Career officials at the Centers for Disease Control and Prevention responsible for overseeing the agency's committee of outside vaccine experts have been removed from their role in the process, multiple CDC officials tell CBS News.

3don MSN

Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

Moderna's shares fell 2.3% in early trading on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The RSV shot,